Skip to main content
. Author manuscript; available in PMC: 2019 Oct 15.
Published in final edited form as: Neuropharmacology. 2018 Jun 5;138:130–139. doi: 10.1016/j.neuropharm.2018.06.003

Fig. 1.

Fig. 1.

Whole brain levels of A) kynurenine and B) KYNA in untreated WT (n = 9) and KMO K/O (n = 7) mice. Bars represent the mean ± SEM, ***p < 0.001 vs. WT, Mann–Whitney U test.